Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT02182921
Recruiting Observational

Evaluation of Cataract Surgery Outcome

NCT02182921 · tracked via the Priya Life Science China tracker
Sponsor
Evidence Based Cataract Study Group
Phase
Observational
Started
2013-08
Last updated
2024-08-28

Condition(s) studied

CataractHigh Myopia

Study summary

The purpose of this study is to evaluate the visual outcome of the cataract surgery, including best uncorrected and corrected visual acuity, spherical equivalent, wavefront aberration and other measurements.

Eligibility

Sex
ALL
Min age
—
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of cataract * Must be able to cooperate with the ophthalmic examination Exclusion Criteria: * Clinical diagnosis of mental illness * Mentally disabled

Primary outcome measure(s)

  • Change from baseline in visual acuity at one month after cataract surgery — Follow-up until one month after surgery
  • Change from baseline in spherical equivalent at one month after cataract surgery — Follow-up until one month after surgery
  • Change from baseline in visual acuity at six months after cataract surgery — Follow-up until six months after surgery
  • Change from baseline in spherical equivalent at six months after cataract surgery — Follow-up until six months after cataract surgery

Trial sites (1)

FacilityCityRegionStatus
Eye and ENT Hospital of Fudan University Shanghai Shanghai Municipality Recruiting

More Evidence Based Cataract Study Group trials in China

Shanghai Pediatric Cataract Study Recruiting
Evaluation on Visual Outcome of TMS Active, not recruiting

Other trials for the same condition

Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye Recruiting
Shanghai High Myopia Study Recruiting
Night Driving After Trifocal Versus Monofocal IOL Implantation Starting soon
Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery Recruiting
Wuhan High Myopia Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02182921 on ClinicalTrials.gov ↗ ← All trials in China